[go: up one dir, main page]

MA31062B1 - Agents tensioactifs reconstitues presentant des proprietes ameliorees. - Google Patents

Agents tensioactifs reconstitues presentant des proprietes ameliorees.

Info

Publication number
MA31062B1
MA31062B1 MA31854A MA31854A MA31062B1 MA 31062 B1 MA31062 B1 MA 31062B1 MA 31854 A MA31854 A MA 31854A MA 31854 A MA31854 A MA 31854A MA 31062 B1 MA31062 B1 MA 31062B1
Authority
MA
Morocco
Prior art keywords
improved properties
reconstituted surfactants
reconstituted
relates
surfactants
Prior art date
Application number
MA31854A
Other languages
Arabic (ar)
English (en)
Inventor
Jan Johansson
Tore Curstedt
Bengt Robertson
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39079026&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA31062(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA31062B1 publication Critical patent/MA31062B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Fire-Extinguishing Compositions (AREA)

Abstract

La présente invention porte sur un agent tensioactif reconstitué comportant un support lipidique, un analogue polypeptidique de la protéine d'agent tensioactif native sp-c, et un analogue polypeptidique de la protéine d'agent tensioactif native sp-b. L'invention porte également sur les compositions pharmaceutiques dudit agent et sur leur utilisation pour le traitement ou la prophylaxie de rds et d'autres maladies respiratoires.
MA31854A 2006-10-13 2009-05-08 Agents tensioactifs reconstitues presentant des proprietes ameliorees. MA31062B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06021521 2006-10-13
PCT/IB2007/002841 WO2008044109A1 (fr) 2006-10-13 2007-09-28 Agents tensioactifs reconstitués présentant des propriétés améliorées

Publications (1)

Publication Number Publication Date
MA31062B1 true MA31062B1 (fr) 2010-01-04

Family

ID=39079026

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31854A MA31062B1 (fr) 2006-10-13 2009-05-08 Agents tensioactifs reconstitues presentant des proprietes ameliorees.

Country Status (35)

Country Link
US (2) US8183210B2 (fr)
EP (1) EP2078038B1 (fr)
JP (2) JP5405307B2 (fr)
KR (1) KR101328851B1 (fr)
CN (2) CN101522711B (fr)
AR (2) AR063263A1 (fr)
AU (1) AU2007306075B2 (fr)
BR (1) BRPI0715317B1 (fr)
CA (1) CA2666344C (fr)
CL (1) CL2007002931A1 (fr)
CO (1) CO6400235A2 (fr)
CY (1) CY1114716T1 (fr)
DK (1) DK2078038T3 (fr)
EA (1) EA015802B1 (fr)
ES (1) ES2438727T3 (fr)
GE (1) GEP20125531B (fr)
HR (1) HRP20140052T1 (fr)
IL (1) IL198075A (fr)
JO (1) JO2963B1 (fr)
MA (1) MA31062B1 (fr)
ME (2) MEP12109A (fr)
MX (1) MX343064B (fr)
MY (1) MY148127A (fr)
NO (1) NO342038B1 (fr)
NZ (1) NZ576189A (fr)
PE (1) PE20081184A1 (fr)
PL (1) PL2078038T3 (fr)
PT (1) PT2078038E (fr)
RS (1) RS53172B (fr)
SI (1) SI2078038T1 (fr)
TN (1) TN2009000099A1 (fr)
TW (1) TWI388333B (fr)
UA (1) UA94477C2 (fr)
WO (1) WO2008044109A1 (fr)
ZA (1) ZA200902481B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563683B2 (en) 2006-07-20 2013-10-22 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (fr) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Agents tensioactifs reconstitués dotés de propriétés améliorées
US8399406B2 (en) 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
CN101948526B (zh) * 2010-09-02 2012-12-05 华东理工大学 一种肺泡表面活性蛋白质(sp-b和sp-c)的分离纯化方法
EP2812018B1 (fr) * 2012-02-09 2018-12-05 University Of Rochester Nouveaux peptides sp-b et sp-c, tensioactifs pulmonaires synthétiques, et leurs utilisations
US20130303726A1 (en) * 2012-04-17 2013-11-14 Chiesi Farmaceutici S.P.A. Method for the preparation of surfactant peptides
WO2014079898A1 (fr) 2012-11-21 2014-05-30 Chiesi Farmaceutici S.P.A. Surfactants pulmonaires reconstitués
CA3008646A1 (fr) 2015-12-17 2017-06-22 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Surfactant pulmonaire synthetique a stabilite et efficacite augmentees
EP3452041A4 (fr) 2016-03-07 2020-11-11 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Compositions et procédés pour l'administration d'agonistes de pparv, peptides tensioactifs et phopholipides
MX2019001854A (es) * 2016-08-24 2019-11-11 Chiesi Farm Spa Formulacion farmaceutica estable que comprende una composicion de tensioactivo pulmonar reconstituido.
US20230257446A1 (en) 2020-01-28 2023-08-17 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
JP2023546297A (ja) * 2020-10-16 2023-11-01 バイオスーペリア テクノロジー，インコーポレイテッド 肺治療組成物
WO2025024609A1 (fr) * 2023-07-25 2025-01-30 Biosuperior Technology, Inc. Polypeptides pour compositions de tensioactifs pulmonaires

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69407292T2 (de) * 1993-06-30 1998-06-25 Genentech Inc Verfahren zur herstellung von liposomen
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
US7065342B1 (en) * 1999-11-23 2006-06-20 Gofigure, L.L.C. System and mobile cellular telephone device for playing recorded music
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1481665A1 (fr) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Nouveaux mélanges lipidiques pour tensioactifs synthétiques
US8563683B2 (en) * 2006-07-20 2013-10-22 University Of Rochester Synthetic lung surfactant and use thereof
EP1997502A1 (fr) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Agents tensioactifs reconstitués dotés de propriétés améliorées
EP2022798A1 (fr) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Peptides synthétiques de surfactant pulmonaire

Also Published As

Publication number Publication date
JO2963B1 (en) 2016-03-15
AR113422A2 (es) 2020-04-29
NO342038B1 (no) 2018-03-19
WO2008044109A1 (fr) 2008-04-17
MEP12109A (en) 2011-12-20
PL2078038T3 (pl) 2014-05-30
TW200824705A (en) 2008-06-16
BRPI0715317A2 (pt) 2013-07-09
EA015802B1 (ru) 2011-12-30
ME02326B (me) 2016-06-20
SI2078038T1 (sl) 2014-02-28
CA2666344C (fr) 2017-04-18
KR20090083892A (ko) 2009-08-04
EA200900373A1 (ru) 2009-10-30
DK2078038T3 (da) 2013-12-02
EP2078038B1 (fr) 2013-11-20
TN2009000099A1 (en) 2010-08-19
KR101328851B1 (ko) 2013-11-14
MX2009003638A (es) 2009-04-22
MY148127A (en) 2013-02-28
PE20081184A1 (es) 2008-09-26
AU2007306075A1 (en) 2008-04-17
JP2013241449A (ja) 2013-12-05
UA94477C2 (ru) 2011-05-10
IL198075A0 (en) 2011-08-01
HK1185274A1 (en) 2014-02-14
IL198075A (en) 2016-04-21
ZA200902481B (en) 2010-07-28
US8183210B2 (en) 2012-05-22
RS53172B (sr) 2014-06-30
HK1134497A1 (en) 2010-04-30
CN101522711B (zh) 2013-11-13
AU2007306075B2 (en) 2012-08-09
JP5405307B2 (ja) 2014-02-05
CA2666344A1 (fr) 2008-04-17
US20130079275A1 (en) 2013-03-28
ES2438727T3 (es) 2014-01-20
CN101522711A (zh) 2009-09-02
BRPI0715317B1 (pt) 2021-10-05
TWI388333B (zh) 2013-03-11
NO20091441L (no) 2009-06-23
JP2010505937A (ja) 2010-02-25
CN103169947B (zh) 2014-10-29
CO6400235A2 (es) 2012-03-15
CY1114716T1 (el) 2016-10-05
EP2078038A1 (fr) 2009-07-15
GEP20125531B (en) 2012-05-25
US20100004173A1 (en) 2010-01-07
CN103169947A (zh) 2013-06-26
MX343064B (es) 2016-10-24
NZ576189A (en) 2011-09-30
CL2007002931A1 (es) 2008-03-24
AR063263A1 (es) 2009-01-14
US9238058B2 (en) 2016-01-19
PT2078038E (pt) 2013-12-12
HRP20140052T1 (hr) 2014-02-28

Similar Documents

Publication Publication Date Title
MA31062B1 (fr) Agents tensioactifs reconstitues presentant des proprietes ameliorees.
ES2846789T3 (es) Composiciones que contienen complejos HC-HA/PTX3 y métodos de uso de los mismos
MX2009012675A (es) Tensioactivos reconstituidos que tienen propiedades mejoradas.
MA33374B1 (fr) Composition de surfactant reconstitué améliorée contenant des analogues de la protéine b du surfactant (sp-b) et de la protéine c du surfactant (sp-c)
ATE242633T1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
EA200401467A1 (ru) Пептиды, полученные из казеина, и их применение в терапии
WO1998033509A3 (fr) Proprietes utiles de la lactoferrine humaine et de variants de celle-ci
ATE431141T1 (de) Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit
US6818621B2 (en) Osteopontin-derived chemotactic and inhibitory agents and uses therefor
DE60025026D1 (de) Antimicrobielle wirkung des ersten kationischen cluster des menschlichen lactoferrins
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
MA29625B1 (fr) Immunoglobulines
AU2017252344A1 (en) Diagnosis of immune_activation using CLEVER-1, TNF-alpha and HLA-DR binding agents
US20240041987A1 (en) Novel bioactive peptide combinations and uses thereof
TW201204384A (en) Lactoferrin sequences, compositions and methods of wound treatment
CA3201966A1 (fr) Pretraitement de csm avec un agoniste de ppar?/? pour le traitement des lesions d'ischemie-reperfusion
PT1317273E (pt) Utilizacao de quimera il-6r/il-6 na doenca de huntington
KR101169850B1 (ko) 트로락스를 포함하는 골 대사성 질환 또는 골 전이성 암 질환 예방 및 치료용 약제학적 조성물
WO2002098454A3 (fr) Molecules recombinees a immunogenicite reduite, procedes et produits intermediaires pour les obtenir et leur utilisation dans des compositions pharmaceutiques et des outils diagnostiques
Samy et al. Wound Healing Activity and Mechanisms of Action of an Antibacterial
TN2010000460A1 (fr) Nouveaux anticorps utiles pour le traitement du cancer